Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care.
Health-related quality of life
IBD nurse specialist
Inflammatory Bowel Disease Questionnaire
Inflammatory bowel disease
Micro-team
Multidisciplinary team
Quality of Life
Quality of care
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
31 Dec 2022
31 Dec 2022
Historique:
received:
07
05
2022
accepted:
19
12
2022
entrez:
31
12
2022
pubmed:
1
1
2023
medline:
4
1
2023
Statut:
epublish
Résumé
Inflammatory bowel disease (IBD), consisting of Crohn's disease (CD) and ulcerative colitis (UC), is a chronic disorder with a considerable negative impact on health-related quality of life (HRQoL). During the past decade, IBD nurse specialists have been increasingly involved in follow-up care of IBD outpatients, in a consultative and coordinating role, closely cooperating with gastroenterologists. Whether patients' HRQoL differs between nurses' follow-up care (NF) and conventional follow-up care (CF) has not been widely researched and the aim of this study was to compare two different follow-up regimes with respect to patients' HRQoL. This cross-sectional, multicenter study involved seven centers; five organized as CF, two as NF. A total of 304 patients aged 18-80 years, 174 females and 130 males, were included, of whom 140 received care under the NF model and 164 under the CF model. Participants in the NF group had a statistically significant higher median total score on the Inflammatory Bowel Disease Questionnaire (IBDQ) (p-value < .001). This pattern could also be seen in the sub-scores of the different IBDQ domains. Despite a trend of higher IBDQ score in all domains in the NF model, the overall result in our study did not reach the limit of 16 points, defined as clinically significant. A higher proportion of NF patients had IBDQ scores defined as remission, as well as a statistically significant higher frequency of outpatient check-ups during a two-year follow-up period. Nurse-led models are not inferior to conventional models with regards to patient reported HRQoL except in the social domain where the model showed to be clinically significant better. Further studies are needed to advance efforts to implement these models and increase access to IBD care.
Sections du résumé
BACKGROUND
BACKGROUND
Inflammatory bowel disease (IBD), consisting of Crohn's disease (CD) and ulcerative colitis (UC), is a chronic disorder with a considerable negative impact on health-related quality of life (HRQoL). During the past decade, IBD nurse specialists have been increasingly involved in follow-up care of IBD outpatients, in a consultative and coordinating role, closely cooperating with gastroenterologists. Whether patients' HRQoL differs between nurses' follow-up care (NF) and conventional follow-up care (CF) has not been widely researched and the aim of this study was to compare two different follow-up regimes with respect to patients' HRQoL.
METHODS
METHODS
This cross-sectional, multicenter study involved seven centers; five organized as CF, two as NF.
RESULTS
RESULTS
A total of 304 patients aged 18-80 years, 174 females and 130 males, were included, of whom 140 received care under the NF model and 164 under the CF model. Participants in the NF group had a statistically significant higher median total score on the Inflammatory Bowel Disease Questionnaire (IBDQ) (p-value < .001). This pattern could also be seen in the sub-scores of the different IBDQ domains. Despite a trend of higher IBDQ score in all domains in the NF model, the overall result in our study did not reach the limit of 16 points, defined as clinically significant. A higher proportion of NF patients had IBDQ scores defined as remission, as well as a statistically significant higher frequency of outpatient check-ups during a two-year follow-up period.
CONCLUSIONS
CONCLUSIONS
Nurse-led models are not inferior to conventional models with regards to patient reported HRQoL except in the social domain where the model showed to be clinically significant better. Further studies are needed to advance efforts to implement these models and increase access to IBD care.
Identifiants
pubmed: 36587197
doi: 10.1186/s12913-022-08985-1
pii: 10.1186/s12913-022-08985-1
pmc: PMC9805028
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1602Informations de copyright
© 2022. The Author(s).
Références
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
J Crohns Colitis. 2012 Oct;6(9):887-94
pubmed: 22398072
Scand J Gastroenterol. 2002 Oct;37(10):1164-74
pubmed: 12408521
J Crohns Colitis. 2019 Jan 01;13(1):127-137
pubmed: 30423033
Gastroenterology. 1989 Mar;96(3):804-10
pubmed: 2644154
J Crohns Colitis. 2014 Sep;8(9):919-26
pubmed: 24713174
Ann Fam Med. 2011 Mar-Apr;9(2):100-3
pubmed: 21403134
J Crohns Colitis. 2014 Mar;8(3):240-51
pubmed: 24295646
J Clin Nurs. 2011 Jun;20(11-12):1578-87
pubmed: 21418363
J Crohns Colitis. 2017 Mar 01;11(3):353-359
pubmed: 27664273
Scand J Gastroenterol. 2004 Apr;39(4):365-73
pubmed: 15125469
J Crohns Colitis. 2013 May;7(4):322-37
pubmed: 23395397
J Crohns Colitis. 2012 Apr;6(3):302-10
pubmed: 22405166
Scand J Gastroenterol. 2016;51(4):434-41
pubmed: 26635189
Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:54-9
pubmed: 15352895
Inflamm Bowel Dis. 1997 Winter;3(4):265-76
pubmed: 23282873
J Crohns Colitis. 2014 May;8(5):370-4
pubmed: 24161810
Gastroenterology. 2004 May;126(6):1504-17
pubmed: 15168363
Hum Resour Health. 2006 Feb 17;4:3
pubmed: 16483384
Scand J Gastroenterol Suppl. 1996;221:26-8
pubmed: 9110394
Dig Dis Sci. 1990 Oct;35(10):1276-80
pubmed: 2209295
J Crohns Colitis. 2018 Jun 28;12(7):760-776
pubmed: 29509882
J Crohns Colitis. 2008 Jun;2(2):181-8
pubmed: 21172209
Eur J Gastroenterol Hepatol. 2000 Sep;12(9):967-73
pubmed: 11007131
Health Qual Life Outcomes. 2017 Sep 15;15(1):177
pubmed: 28915891
BMC Health Serv Res. 2016 Jul 08;16:231
pubmed: 27391695
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):646-650
pubmed: 28118176
J Pediatr Gastroenterol Nutr. 1999 Apr;28(4):S23-7
pubmed: 10204520
Frontline Gastroenterol. 2015 Oct;6(4):290-297
pubmed: 28839825
Scand J Gastroenterol Suppl. 1993;199:22-7
pubmed: 8171295